Taylor Wealth Management Partners Eli Lilly & CO Transaction History

Taylor Wealth Management Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $11,131 - $13,102	-100 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$85.86 - $107.31 $8,586 - $10,731	100 New	100 $11,000
Q1 2018 Apr 11, 2018	SELL	$74.21 - $87.6 $115,025 - $135,780	-1,550 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$77.07 - $85.54 $119,458 - $132,587	1,550	1,550 $133,000

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Taylor Wealth Management Partners, based on Form 13F filings with the SEC.

Stay updated on Taylor Wealth Management Partners with notifications on news.